Stay updated on Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial
Sign up to get notified when there's something new on the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page.

Latest updates to the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page
- Check4 days agoChange DetectedA site-wide government funding notice banner was added and the revision tag was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check11 days agoChange DetectedAdded a glossary toggle in the header and introduced metadata labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with revision updated to v3.4.0. Removed the older labels 'Last Update Submitted that met QC Criteria' (lowercase 'met'), 'No FEAR Act data', and the previous revision note v3.3.4.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check47 days agoChange DetectedFooter now displays Revision: v3.3.3. The HHS Vulnerability Disclosure link and the Revision: v3.3.2 entry were removed.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page revision label updated from v3.3.1 to v3.3.2. No substantive study information appears to be changed.SummaryDifference0.1%

- Check75 days agoChange DetectedThe Publications section is now described as automatically filled from PubMed and may not be about the study. The revision label was updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check83 days agoChange DetectedRemoved the banner notice about a lapse in government funding and the NIH operating status, which previously directed users to opm.gov for status updates. This change affects only operational messaging and does not alter the study details, eligibility criteria, or listed results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page.